10 - 11 MARCH Preclinical and Translational Immuno-Oncology
10 - 11 MARCH Immunomodulatory Approaches
10 - 11 MARCH CARs, TILs, TCRs
11 - 12 MARCH Biomarkers for Immuno-Oncology
11 - 12 MARCH Combination Immunotherapy
11 - 12 MARCH Bispecific Antibody Design and Applications
250+
I-O
Thought Leaders
100+
Scientific Presentations
9
Days of Programming
30%
Executive-Level Delegates


2019 Featured Speakers

Christian Klein, PhD
Distinguished Scientist & Head, Oncology Programs, Roche Innovation Center Zurich

Sergio A Quezada, PhD
Professor, University College London Cancer Institute

Roy Baynes, MD
Senior Vice President, Global Clinical Development & CMO, Merck Sharp & Dohme

Ed Schuuring, PhD
Professor & Head, Molecular Pathology, University Medical Center Groningen

Sara Colombetti, PhD
Head of Oncology Discovery Pharmacology, Pharmacology, Roche Innovation Center Zurich

Hinrich Abken, PhD
Professor, Chair Gene-Immunotherapy, Regensburg Center for Interventional Immunology, University Regensburg

Frank Tufaro, PhD
CEO, DNAtrix, Inc.

 

VIEW ADDITIONAL ATTENDEE QUOTES

 

Preliminary Agenda Now Available
Attendee Breakdown


ABOUT THE EVENT

Cambridge Healthtech Institute’s Fifth Immuno-Oncology Summit Europe returns to the heart of London’s Canary Wharf for 3 days of cutting edge science and discussion. Through six conference tracks, delegates will hear from the research teams at the forefront of the rapidly developing field of cancer biotherapeutics.